A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: rationale and design of the evaluation of MCC-135 for left ventricular salvage in acute MI (EVOLVE) study.
J Thromb Thrombolysis
; 20(3): 147-53, 2005 Dec.
Article
in En
| MEDLINE
| ID: mdl-16261287
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Piperazines
/
Benzenesulfonates
/
Angioplasty, Balloon, Coronary
/
Calcium
/
Ventricular Function, Left
/
Muscle Cells
/
Myocardial Infarction
Type of study:
Clinical_trials
/
Diagnostic_studies
Limits:
Adolescent
/
Adult
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Thromb Thrombolysis
Journal subject:
ANGIOLOGIA
Year:
2005
Document type:
Article
Affiliation country:
United States